Lutetium Lu 177 Dotatate

Lutetium Lu 177 Dotatate is a pharmaceutical-grade active ingredient classified as Radiopharmaceutical / Peptide Receptor Radionuclide Therapy. Mediocon Inc supplies high-purity Lutetium Lu 177 Dotatate API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Key Features

• Targeted radiopharmaceutical for IV use
• For radiopharmaceutical use only
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
• Midgut neuroendocrine tumors
• PRRT — Peptide Receptor Radionuclide Therapy

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings